عنوان
پدید آورنده
موضوع
رده
RM301.27 .S96 2007eb
RM301
.
27
.
S96
2007eb
کتابخانه
محل استقرار
INTERNATIONAL STANDARD BOOK NUMBER
(Number (ISBN
0309109876
(Number (ISBN
1281093556
(Number (ISBN
6611093559
(Number (ISBN
9780309109871
(Number (ISBN
9781281093554
(Number (ISBN
9786611093556
Erroneous ISBN
0309109868
Erroneous ISBN
9780309109864
NATIONAL BIBLIOGRAPHY NUMBER
Number
b787527
TITLE AND STATEMENT OF RESPONSIBILITY
Title Proper
Challenges for the FDA :
General Material Designation
[Book]
Other Title Information
the Future of Drug Safety : Workshop Summary /
First Statement of Responsibility
Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies ; Leslie Pray and Sally Robinson, rapporteurs.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Washington, DC :
Name of Publisher, Distributor, etc.
National Academies Press,
Date of Publication, Distribution, etc.
©2007.
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
1 online resource (xvii, 109 pages) :
Other Physical Details
illustrations
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references (pages 78-79).
CONTENTS NOTE
Text of Note
Addressing the FDA's Resource Challenges -- Strengthening the Scientific Base of the Agency -- Integrating Pre- and Postmarket Review -- Enhancing Postmarket Safety Monitoring -- Conducting Confirmatory Drug Safety and Efficacy Studies -- Enhancing the Value of Clinical Trial Registration -- Enhancing Postmarket Regulation and Enforcement -- Looking to the Future.
0
OTHER EDITION IN ANOTHER MEDIUM
Title
Challenges for the FDA.
International Standard Book Number
9780309109864
CORPORATE BODY NAME USED AS SUBJECT
United States.-- Rules and practice.
United States
United States-- rules & practice
United States.
TOPICAL NAME USED AS SUBJECT
Drugs-- United States-- Safety measures, Congresses.
Drugs-- United States-- Testing, Congresses.
Adverse Drug Reaction Reporting Systems-- organization & administration.
Drug Approval-- organization & administration.
Drug Approval.
Drug Approval.
Drug Evaluation, Preclinical-- standards.
Drug Interactions.
Drug-Related Side Effects and Adverse Reactions-- prevention & control.
Drug-Related Side Effects and Adverse Reactions.
Drug-Related Side Effects and Adverse Reactions.
Government Agencies.
Product Surveillance, Postmarketing-- standards.
Product Surveillance, Postmarketing.
Safety.
United States Food and Drug Administration
Drugs-- Safety measures.
Drugs-- Testing.
MEDICAL-- Drug Guides.
MEDICAL-- Nursing-- Pharmacology.
MEDICAL-- Pharmacology.
MEDICAL-- Pharmacy.
GEOGRAPHICAL NAME USED AS SUBJECT
United States.
United States.
2
7
(SUBJECT CATEGORY (Provisional
K
MED-- 023000
MED-- 058170
MED-- 071000
MED-- 072000
DEWEY DECIMAL CLASSIFICATION
Number
615/
.
19
Edition
22
LIBRARY OF CONGRESS CLASSIFICATION
Class number
RM301
.
27
Book number
.
S96
2007eb
OTHER CLASS NUMBERS
Class number
2007
L-855
Class number
QV
771
Book Number
S9889c
2007
PERSONAL NAME - ALTERNATIVE RESPONSIBILITY
Pray, Leslie A.
Robinson, Sally.
CORPORATE BODY NAME - PRIMARY RESPONSIBILITY
Symposium on the Future of Drug Safety: Challenges for the FDA(2007 :, Washington, D.C.)
CORPORATE BODY NAME - ALTERNATIVE RESPONSIBILITY
Institute of Medicine (U.S.)., Forum on Drug Discovery, Development, and Translation.
ORIGINATING SOURCE
Date of Transaction
20201207011209.0
Cataloguing Rules (Descriptive Conventions))
pn
ELECTRONIC LOCATION AND ACCESS
Electronic name
مطالعه متن کتاب [Book]
Y
